Roux-Y Gastric Bypass and Sleeve Gastrectomy directly change gut microbiota composition independent of surgery type.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
29 07 2019
Historique:
received: 04 12 2018
accepted: 08 07 2019
entrez: 31 7 2019
pubmed: 31 7 2019
medline: 27 10 2020
Statut: epublish

Résumé

Bariatric surgery in morbid obesity, either through sleeve gastrectomy (SG) or Roux-Y gastric bypass (RYGB), leads to sustainable weight loss, improvement of metabolic disorders and changes in intestinal microbiota. Yet, the relationship between changes in gut microbiota, weight loss and surgical procedure remains incompletely understood. We determined temporal changes in microbiota composition in 45 obese patients undergoing crash diet followed by SG (n = 22) or RYGB (n = 23). Intestinal microbiota composition was determined before intervention (baseline, S1), 2 weeks after crash diet (S2), and 1 week (S3), 3 months (S4) and 6 months (S5) after surgery. Relative to S1, the microbial diversity index declined at S2 and S3 (p < 0.05), and gradually returned to baseline levels at S5. Rikenellaceae relative abundance increased and Ruminococcaceae and Streptococcaceae abundance decreased at S2 (p < 0.05). At S3, Bifidobacteriaceae abundance decreased, whereas those of Streptococcaceae and Enterobacteriaceae increased (p < 0.05). Increased weight loss between S3-S5 was not associated with major changes in microbiota composition. No significant differences appeared between both surgical procedures. In conclusion, undergoing a crash diet and bariatric surgery were associated with an immediate but temporary decline in microbial diversity, with immediate and permanent changes in microbiota composition, independent of surgery type.

Identifiants

pubmed: 31358818
doi: 10.1038/s41598-019-47332-z
pii: 10.1038/s41598-019-47332-z
pmc: PMC6662812
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

10979

Références

Diabetes Metab Res Rev. 2017 Mar;33(3):
pubmed: 27572277
Nutr Metab (Lond). 2016 Feb 20;13:14
pubmed: 26900391
Diabetes. 2010 Dec;59(12):3049-57
pubmed: 20876719
JAMA Surg. 2013 Jun;148(6):563-9
pubmed: 23571517
Gut. 2011 Sep;60(9):1214-23
pubmed: 21572120
Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16731-6
pubmed: 18936492
Diabetes. 2016 Oct;65(10):2990-3001
pubmed: 27431457
Am J Clin Nutr. 2013 Jul;98(1):16-24
pubmed: 23719559
Gut. 2019 Jan;68(1):70-82
pubmed: 29899081
Appl Environ Microbiol. 1997 Jul;63(7):2802-13
pubmed: 9212428
Front Microbiol. 2016 Feb 23;7:200
pubmed: 26941724
Cell Metab. 2015 Aug 4;22(2):228-38
pubmed: 26244932
Eur J Endocrinol. 2018 Jan;178(1):43-56
pubmed: 28916564
Can J Microbiol. 2016 Aug;62(8):692-703
pubmed: 27314511
Genome Med. 2016 Jun 15;8(1):67
pubmed: 27306058
Nat Methods. 2010 May;7(5):335-6
pubmed: 20383131
BMC Bioinformatics. 2008 Jul 09;9:303
pubmed: 18613966
ISME J. 2017 Sep;11(9):2047-2058
pubmed: 28548658
J Clin Gastroenterol. 2010 Sep;44 Suppl 1:S16-8
pubmed: 20535027
Biomed Res Int. 2015;2015:806248
pubmed: 25710027
Obes Surg. 2017 Apr;27(4):917-925
pubmed: 27738970
Microbiome. 2014 Feb 24;2(1):6
pubmed: 24558975
Trends Endocrinol Metab. 2018 Mar;29(3):140-150
pubmed: 29409713
Nat Med. 2017 Jul;23(7):859-868
pubmed: 28628112
Bioinformatics. 2010 Oct 1;26(19):2460-1
pubmed: 20709691
Proc Natl Acad Sci U S A. 2009 Feb 17;106(7):2365-70
pubmed: 19164560
Bioinformatics. 2011 Nov 1;27(21):2957-63
pubmed: 21903629
Pharmacogenomics J. 2013 Dec;13(6):514-22
pubmed: 23032991
Biochim Biophys Acta. 1972 Mar 30;264(1):85-97
pubmed: 4553810
Cell Host Microbe. 2008 Apr 17;3(4):213-23
pubmed: 18407065
Microb Ecol Health Dis. 2015 May 29;26:27663
pubmed: 26028277
Sci Transl Med. 2013 Mar 27;5(178):178ra41
pubmed: 23536013
Am J Physiol Regul Integr Comp Physiol. 2011 Oct;301(4):R1057-66
pubmed: 21734019
Obes Surg. 2017 Feb;27(2):295-302
pubmed: 27440168
Obes Surg. 2014 Sep;24(9):1567-71
pubmed: 24849914

Auteurs

Fernanda L Paganelli (FL)

Department of Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Misha Luyer (M)

Department of Surgery, Catharina Hospital Eindhoven, Eindhoven, The Netherlands.

C Marijn Hazelbag (CM)

Department of Biostatistics and Research Support, Julius Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Hae-Won Uh (HW)

Department of Biostatistics and Research Support, Julius Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Malbert R C Rogers (MRC)

Department of Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Danielle Adriaans (D)

Department of Surgery, Catharina Hospital Eindhoven, Eindhoven, The Netherlands.

Roos-Marijn Berbers (RM)

Department of Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Antoni P A Hendrickx (APA)

Department of Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Marco C Viveen (MC)

Department of Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

James A Groot (JA)

Department of Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Marc J M Bonten (MJM)

Department of Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Ad C Fluit (AC)

Department of Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Rob J L Willems (RJL)

Department of Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Helen L Leavis (HL)

Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. h.leavis@umcutrecht.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH